DNA – media

DNA Testing of Babies Could Save Lives but Still Raises Questions

A hospital in the US is among the first to offer rapid genome sequencing of critically ill newborns to help identify the cause of their illnesses, which could save their lives. This technology could be used on healthy babies too. But some experts raise concerns about sequencing every baby at birth.
- Source: https://emag.medicalexpo.com/dna-testing-babies-could-save-lives-of-newborns/
- 519
- June 2, 2020
DNA GENETICS genome sequencing NEWBORNS Pediatrics
Artios Pharma raises $84 Million to take DDR Programs to Next Level

Artios Pharma, a U.K. based company in Cambridge, has raised $84 million to take DNA damage response (DDR) programs to the next level of clinical proof of concept.
- Source: FierceBiotech
- 1,081
- August 14, 2018
cancer Company Insight DNA
Study Unravels New Protein Complex that Repairs Broken DNA Ends

In a major breakthrough in cancer research, a team of scientists from the University of Toronto, The Institute of Cancer Research, London, The Netherlands Cancer Institute and the University of Bern have discovered how cells repair damaged strands of DNA. They revealed a brand new protein complex in cells that protect broken DNA ends and causes its repair, in their study published in Nature on Wednesday.
- Source: News Medical
- 833
- July 23, 2018
cancer DNA Researches
Precision Medicine – An Ultimate Panacea

Precision medicine is an emerging approach for disease treatment where genes, the environment and lifestyle of each person is taken into account.
- Source: FierceHealthcare
- 585
- June 19, 2018
DNA precision medicine Researches
Accent raised $40 Million to Develop Epitranscriptomics Studies

Cambridge, Mass.-based Biotech startup Accent Therapeutics announced $40 million A series funding to develop cancer treatment based on epitranscriptomics, an RNA-modifying protein (RMPs) which have been connected to recent cancer studies.
- Source: Ddu
- 673
- May 21, 2018
biotech cancer Company Insight DNA
SIGA Technologies Announces FDA Accepts NDA and Grants Priority Review for Oral TPOXX to Treat Smallpox

SIGA Technologies, Inc. (SIGA) (OTCMKTS:SIGA), a health security company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats, today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s New Drug Application (NDA) for its oral formulation of TPOXX® (tecovirimat).
- Source: investor.siga
- 609
- February 9, 2018
DNA FDA New Approvals TPOXX
Nicotine in E-cigarettes damages DNA, mouse study suggests

The nicotine in e-cigarettes seems to damage DNA in ways that may increase cancer risk, a new study in mice suggests.
- Source: medicalxpress
- 614
- February 6, 2018
cancer DNA e-cigarettes nicotine Researches
Afatinib Approval Expanded for Rare Lung Cancer Treatment

Boehringer Ingelheim announced the approval of a new indication for afatinib (Gilotrif), as the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application (NDA) for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have non-resistant epidermal growth factor receptor (EGFR) mutations as detected by an FDA-approved test.
- Source: Raredr
- 715
- January 17, 2018
afatinib DNA FDA New Approvals NSCLC
CRISPR shows potential to reduce diseases spread by mosquitoes

Researchers at the University of California, Riverside, have shown that it is possible for transgenic mosquitos to stably express the Cas9 enzyme in their germline. Cas9 addition will allow the utilization of the CRISPR gene editing tool to carry out efficient and highly targeted changes to the DNA of the mosquitoes.
- Source: news-medical
- 536
- November 21, 2017
CAS9 CRISPR DNA enzyme Researches

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.